According to a new Research on Global Markets report, the global biological and medical imaging reagents market is expected to be worth approximately USD 11.22 Bn by 2022, expanding at a compound annual growth rate (CAGR) of 8% during the 2017-2022 period. The rising number of deaths due to cancer and cardiac illness is driving the demand for advanced diagnostic procedures and techniques, for faster and efficient detection of such conditions. As a result, the need for biological and medical imaging reagents is increasing across the world.

The global biological and medical imaging reagents market is segmented based on class, application, routes of administration, and end use. Based on class, contrast reagents dominate the market, since it is used extensively in multiple diagnostic procedures like magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT), and x-rays. The radiopharmaceuticals segment, on the other hand, held a market share of approximately 28%, and has been witnessing consolidation over the past few years.

According to Research on Global Markets, x-rays are the most widely used application of biological and medical imaging reagents. PET and CT occupies the second-largest segment, in terms of application, with an approximate market share of 29%. The MRI segment, holding a 15.1% share in 2017, is anticipated to witness the highest CAGR during the forecasted period.

Check out the Research on Global Markets report featured in this article:

Global Biological and Medical Imaging Reagents Market (2017-2022)
January 2019 | 90-100 Pages | SKU: 201858

Based on the routes of administration, imaging reagents administered through injections currently holds the largest market share (62%), and is also expected to witness the highest CAGR during the forecasted period.

Based on end use, the diagnosis segment accounted for the highest revenue in 2017, and is expected to maintain a similar revenue generation trend during the forecasted period, according to Research on Global Markets.  

Research on Global Markets tracks the performance of the global biological and medical imaging reagents market across the key geographies of North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa. North America held the largest share (45%) of the global market in 2017, driven by the concerted efforts of the Food and Drug Administration (FDA), National Cancer Institute (NCI), the pharmaceutical industry, and academia.

Key highlights of this report:

  • Market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
  • Qualitative analysis of the drivers and challenges affecting the global market
  • Major trends in the global biological and medical imaging reagents market
  • Analysis of the competitive landscape and profiles of the major players operating in the market
  • Market segmentation based on class (contrast reagents, radiopharmaceuticals, and optical reagents) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
  • Market segmentation based on application (magnetic resonance imaging [MRI], positron emission tomography [PET] and computed tomography [CT], x-rays, and ultrasonography [USG]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
  • Market segmentation based on routes of administration (injection, oral, and enema) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
  • Market segmentation based on end use (diagnosis, drug discovery, and research and development [R&D]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
  • Market segmentation based on region (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa)

This report has been formulated and designed with the purpose of giving businesses a concise understanding of the demand for biological and medical imaging reagent products across the world, to determine the viability of the market, develop strategies based on the drivers, and to help brands identify competition and respond accordingly.

Name: Ankita Basu
Email: ankita.basu@netscribes.com
US Toll-Free: 18888313350
M: +91 9903154956